Kasinath Viswanathan

1.6k total citations
26 papers, 1.3k citations indexed

About

Kasinath Viswanathan is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Kasinath Viswanathan has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Kasinath Viswanathan's work include Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (4 papers). Kasinath Viswanathan is often cited by papers focused on Herpesvirus Infections and Treatments (6 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (4 papers). Kasinath Viswanathan collaborates with scholars based in United States, India and Canada. Kasinath Viswanathan's co-authors include Klaus Früh, Janet L. Douglas, Ashlee V. Moses, Jean K. Gustin, Mandana Mansouri, Matthew N. McCarroll, Craig Eyster, Julie G. Donaldson, Victor R. DeFilippis and Daniel Malouli and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Kasinath Viswanathan

23 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kasinath Viswanathan United States 16 468 467 446 431 215 26 1.3k
Véronique Robert-Hebmann France 22 740 1.6× 706 1.5× 481 1.1× 366 0.8× 245 1.1× 37 1.5k
Wenchang Zhou China 7 484 1.0× 363 0.8× 180 0.4× 452 1.0× 220 1.0× 9 1.0k
Chad M. Swanson United Kingdom 24 630 1.3× 511 1.1× 375 0.8× 875 2.0× 458 2.1× 38 1.6k
Elana S. Ehrlich United States 15 754 1.6× 398 0.9× 314 0.7× 466 1.1× 499 2.3× 19 1.2k
Christian Knabenhans Switzerland 7 676 1.4× 1.0k 2.2× 341 0.8× 476 1.1× 348 1.6× 10 1.9k
Karen Duus United States 22 270 0.6× 545 1.2× 348 0.8× 284 0.7× 225 1.0× 34 1.3k
L Bergeron United States 10 477 1.0× 347 0.7× 214 0.5× 790 1.8× 274 1.3× 15 1.3k
Jérôme Bouchet France 22 471 1.0× 535 1.1× 162 0.4× 846 2.0× 308 1.4× 35 1.6k
Ling‐Jun Zhao United States 23 701 1.5× 480 1.0× 269 0.6× 971 2.3× 439 2.0× 62 1.9k
Rebecca S. LaRue United States 18 797 1.7× 529 1.1× 517 1.2× 711 1.6× 464 2.2× 30 1.7k

Countries citing papers authored by Kasinath Viswanathan

Since Specialization
Citations

This map shows the geographic impact of Kasinath Viswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasinath Viswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasinath Viswanathan more than expected).

Fields of papers citing papers by Kasinath Viswanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasinath Viswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasinath Viswanathan. The network helps show where Kasinath Viswanathan may publish in the future.

Co-authorship network of co-authors of Kasinath Viswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Kasinath Viswanathan. A scholar is included among the top collaborators of Kasinath Viswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasinath Viswanathan. Kasinath Viswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Viswanathan, Kasinath, et al.. (2024). Discovery of aminopiperidine based potent & novel topoisomerase inhibitor with broad spectrum anti-bacterial activity. Bioorganic & Medicinal Chemistry Letters. 111. 129911–129911.
3.
Bahekar, Rajesh, et al.. (2024). Design and Biological Evaluation of Cephalosporin Based Metallo-β-lactamase (MBL) Inhibitors. Letters in Drug Design & Discovery. 21(16). 3506–3514.
4.
Chatterjee, Abhijit, Hiren V. Patel, Harilal Patel, et al.. (2024). A novel selective NLRP3 inhibitor shows disease-modifying potential in animal models of Parkinson’s disease. Brain Research. 1842. 149129–149129. 7 indexed citations
5.
Parmar, Dhruvanshu, Kevinkumar Kansagra, Chintan Shah, et al.. (2022). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First‐in‐Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose). Clinical Pharmacology in Drug Development. 12(2). 202–211. 50 indexed citations
6.
Viswanathan, Kasinath, et al.. (2017). Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus. PLoS ONE. 12(11). e0187899–e0187899. 15 indexed citations
7.
Lucas, Alexandra, Sriram Ambadapadi, Brian P. Mahon, Kasinath Viswanathan, & Hao Chen. (2017). The Serpintine Solution. Journal of Clinical & Experimental Cardiology. 8(1). 1 indexed citations
8.
Viswanathan, Kasinath, Ilze Bot, Liying Liu, et al.. (2012). Viral Cross-Class Serpin Inhibits Vascular Inflammation and T Lymphocyte Fratricide; A Study in Rodent Models In Vivo and Human Cell Lines In Vitro. PLoS ONE. 7(9). e44694–e44694. 27 indexed citations
9.
Malouli, Daniel, Ernesto Nakayasu, Kasinath Viswanathan, et al.. (2012). Reevaluation of the Coding Potential and Proteomic Analysis of the BAC-Derived Rhesus Cytomegalovirus Strain 68-1. Journal of Virology. 86(17). 8959–8973. 33 indexed citations
10.
Korol, Renée, Peter B. Canham, Li Liu, et al.. (2011). Detection of Altered Extracellular Matrix in Surface Layers of Unstable Carotid Plaque: An Optical Spectroscopy, Birefringence and Microarray Genetic Analysis. Photochemistry and Photobiology. 87(5). 1164–1172. 10 indexed citations
11.
Viswanathan, Kasinath, M. Shane Smith, Daniel Malouli, et al.. (2011). BST2/Tetherin Enhances Entry of Human Cytomegalovirus. PLoS Pathogens. 7(11). e1002332–e1002332. 60 indexed citations
12.
Bartee, Eric, Craig Eyster, Kasinath Viswanathan, et al.. (2010). Membrane-Associated RING-CH Proteins Associate with Bap31 and Target CD81 and CD44 to Lysosomes. PLoS ONE. 5(12). e15132–e15132. 67 indexed citations
13.
Douglas, Janet L., Jean K. Gustin, Kasinath Viswanathan, et al.. (2010). The Great Escape: Viral Strategies to Counter BST-2/Tetherin. PLoS Pathogens. 6(5). e1000913–e1000913. 96 indexed citations
14.
Viswanathan, Kasinath, Klaus Früh, & Victor R. DeFilippis. (2010). Viral hijacking of the host ubiquitin system to evade interferon responses. Current Opinion in Microbiology. 13(4). 517–523. 63 indexed citations
15.
Mansouri, Mandana, Kasinath Viswanathan, Janet L. Douglas, et al.. (2009). Molecular Mechanism of BST2/Tetherin Downregulation by K5/MIR2 of Kaposi's Sarcoma-Associated Herpesvirus. Journal of Virology. 83(19). 9672–9681. 220 indexed citations
16.
Richardson, Mary, Liying Liu, David Wong, et al.. (2007). Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model. Cardiovascular Pathology. 16(4). 191–202. 15 indexed citations
17.
Viswanathan, Kasinath, et al.. (2006). Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways. Thrombosis and Haemostasis. 95(3). 499–510. 34 indexed citations
18.
Dai, Erbin, Kasinath Viswanathan, Xing Li, et al.. (2006). Identification of Myxomaviral Serpin Reactive Site Loop Sequences That Regulate Innate Immune Responses. Journal of Biological Chemistry. 281(12). 8041–8050. 36 indexed citations
19.
Dai, Erbin, Liying Liu, Kasinath Viswanathan, et al.. (2006). C-terminal apolipoprotein E-derived peptide, Ep1.B, displays anti-atherogenic activity. Atherosclerosis. 194(1). 116–124. 14 indexed citations
20.
Viswanathan, Kasinath, Erbin Dai, P. Turner, et al.. (2004). 803-4 Analysis of anti-apoptotic intracellular viral serpins as anti-atherosclerotic agents. Journal of the American College of Cardiology. 43(5). A54–A54.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Véronique Robert-Hebmann Breakdown of academic impact, for papers by Wenchang Zhou Breakdown of academic impact, for papers by Chad M. Swanson Breakdown of academic impact, for papers by Elana S. Ehrlich Breakdown of academic impact, for papers by Christian Knabenhans Breakdown of academic impact, for papers by Karen Duus Breakdown of academic impact, for papers by L Bergeron Breakdown of academic impact, for papers by Jérôme Bouchet Breakdown of academic impact, for papers by Ling‐Jun Zhao Breakdown of academic impact, for papers by Rebecca S. LaRue
Rankless by CCL
2026